球囊辅助内镜ERCP与EUS引导治疗在Roux-en-Y胃切除术后胆总管结石中的比较
本研究在16中心回顾性分析Roux-en-Y胃切除术后胆总管结石患者,比较球囊辅助内镜ERCP(BE-ERCP,588例)与EUS引导顺行治疗(EUS-AG,59例)。两组技术成功率和完全取石率无显著差异,但BE-ERCP在胆道通路建立后完全取石率更高,且内镜次数更少、总治疗时间更长。
要点
- BE-ERCP与EUS-AG技术成功率分别为83.7%与83.1%,无显著差异(P=.956)
- 胆道通路建立后BE-ERCP完全取石率显著高于EUS-AG(93.3% vs 81.6%,P=.009)
- BE-ERCP内镜次数更少但总治疗时间更长
核心结论
- 在Roux-en-Y胃切除术后胆总管结石患者中,BE-ERCP与EUS-AG的有效性和安全性相当,但BE-ERCP在技术成功后完全取石率更优。
研究设计与样本
- 回顾性分析16中心连续既往Roux-en-Y胃切除术因胆总管结石行BE-ERCP或EUS-AG的患者,BE-ERCP组588例、EUS-AG组59例。
主要发现
- 技术成功率BE-ERCP组83.7% vs EUS-AG组83.1%(P=.956),完全取石率78.1% vs 67.8%(P=.102),早期不良事件率10.2% vs 18.6%(P=.076)。
- 平均内镜次数BE-ERCP组1.5±.8次 vs EUS-AG组1.9±1.0次(P=.01),中位总治疗时间90分钟 vs 61.5分钟(P=.001)。
- 胆道通路建立后完全取石率BE-ERCP组93.3% vs EUS-AG组81.6%(P=.009)。
- BE-ERCP组负性预测因素为胆总管直径≥15 mm(OR=.41)和胆总管角度<90度(OR=.39);EUS-AG组为结石大小≥10 mm(OR=.07)和胆总管角度<90度(OR=.07)。
- 1年复发率两组均为8.3%。
局限性
- 本研究为回顾性分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: We compared ERCP using a balloon-assisted endoscope (BE-ERCP) with EUS-guided antegrade treatment (EUS-AG) for removal of common bile duct (CBD) stones in patients with Roux-en-Y (R-Y) gastrectomy. METHODS: Consecutive patients who had previous R-Y gastrectomy undergoing BE-ERCP or EUS-AG for CBD stones in 16 centers were retrospectively analyzed. RESULTS: BE-ERCP and EUS-AG were performed in 588 and 59 patients, respectively. Baseline characteristics were similar, except for CBD diameter and angle. The technical success rate was 83.7% versus 83.1% (P = .956), complete stone removal rate was 78.1% versus 67.8% (P = .102), and early adverse event rate was 10.2% versus 18.6% (P = .076) in BE-ERCP and EUS-AG, respectively. The mean number of endoscopic sessions was smaller in BE-ERCP (1.5 ± .8 vs 1.9 ± 1.0 sessions, P = .01), whereas the median total treatment time was longer (90 vs 61.5 minutes, P = .001). Among patients with biliary access, the complete stone removal rate was significantly higher in BE-ERCP (93.3% vs 81.6%, P = .009). Negative predictive factors were CBD diameter ≥15 mm (odds ratio [OR], .41) and an angle of CBD <90 degrees (OR, .39) in BE-ERCP and a stone size ≥10 mm (OR, .07) and an angle of CBD <90 degrees (OR, .07) in EUS-AG. The 1-year recurrence rate was 8.3% in both groups. CONCLUSIONS: Effectiveness and safety of BE-ERCP and EUS-AG were comparable in CBD stone removal for patients after R-Y gastrectomy, but complete stone removal after technical success was superior in BE-ERCP.
引用
- Sato T, Nakai Y, Kogure H, et al. ERCP using balloon-assisted endoscopes versus EUS-guided treatment for common bile duct stones in Roux-en-Y gastrectomy. Gastrointest Endosc. 2023. PMID: 37709151. doi:10.1016/j.gie.2023.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。